FridayFeb 10, 2023 1:21 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD Demonstrates Higher Absorption at Lower Dose Levels

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced it had demonstrated superior CBD blood absorption levels from its patented DehydraTECH(TM)-processed CBD compared to those of published comparators. “In their analysis, Lexaria’s researchers compared the average blood plasma levels of DehydraTECH-CBD at various dose levels (after the steady state or the amount of time needed before a consistent dose of drug achieves a stable plasma level had been reached) with that of non-Lexaria, pharmaceutical-grade CBD formulations published in two studies – a 2017 clinical trial and a 2019 study,” a recent article reads. “The 2017 trial evidenced an average blood plasma CBD…

Continue Reading

WednesdayFeb 08, 2023 2:16 pm

TinyGemsBreaks – Vision Energy Corp. (VENG) Reports on Final Results of Jetty Simulation Study

Vision Energy (OTCQB: VENG), a forward-looking energy company developing carbon-reduced solutions for the commercial, industrial and transportation sector, has concluded a detailed marine simulation study; the study will be used for the proposed design and future operations of jetty and quay wall infrastructure that will serve VENG’s Green Energy Hub in North Sea Port of Vlissingen, the Netherlands. According to the announcement, Evolution Terminals BV, a wholly owned subsidiary of Vision Energy, contracted with Maritime Research Institute Netherlands (“MARIN”) to carry out the study, which was conducted in cooperation with North Sea Port authority. MARIN is an internationally operating, leading independent…

Continue Reading

TuesdayFeb 07, 2023 11:57 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls First Patient in Spain in Key Global Trial Studying Berubicin for Treatment of GBM

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced that enrollment is continuing in its ongoing global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”). Specifically, the company is reporting that it has enrolled the first patient in Spain. As part of the trial, the company has opened 37 of 59 planned clinical trial sites; the sites are located in the United States, Italy, France, Spain and Switzerland. The company noted that it plans an interim analysis of the study when…

Continue Reading

MondayFeb 06, 2023 3:44 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Robot Roadshow to Take the Spotlight in Vegas

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, today announced that its Robot Roadshow will land at Silverton Hotel & Casino in Las Vegas, Nevada, from 10:00 a.m. to 2:00 p.m. PT on Feb. 7-9, 2023. The engaging experiential event is designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Las Vegas Roadshow landing will be guided by Knightscope experts, and visitors will be able to interact directly with each of the ASRs and see the Knightscope Security Operations Center (‘KSOC’) user interface in action.…

Continue Reading

MondayFeb 06, 2023 10:43 am

TinyGemsBreaks — Cepton Inc. (NASDAQ: CPTN) Wins Largest Commercial Lidar Deployment Contract in Tolling Sector to Date

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has been awarded a multimillion sales contract from one of the leading U.S. highway tolling systems in the country. The company announced that its exclusive, state-of-the-art lidar solution will be deployed nationwide; the contract is designed to improve and enable accurate and intelligent tolling applications. According to the announcement, the large-scale contract calls for CPTN’s Sora series lidar sensors to be positioned on several major tollways located in the Tri-State area and Northern California in what is projected to be the largest commercial lidar deployment in the tolling…

Continue Reading

FridayFeb 03, 2023 11:50 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Pleased with Early Results from Global Clinical Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently reported that 67 patients have enrolled in the potentially pivotal phase 2 globally cited clinical study comparing drug candidate Berubicin’s effectiveness to second-line standard-of-care chemotherapy drug Lomustine. “The  company plans to have more than 200 patients participate in the clinical trial on a 2:1 randomization schema between those receiving Berubicin and those receiving Lomustine… Berubicin’s performance in an initial safety trial conducted by another company in 2006 resulted in apparent life extension for some patients and complete remission for one patient who, unusually, survives nearly 17 years later. The ongoing study now seeks to demonstrate…

Continue Reading

ThursdayFeb 02, 2023 1:57 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Partners with Loop Global, Menzies Aviation on LAX Pilot Program

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is collaborating with Menzies Aviation and Loop Global Inc. on a pilot program at the Los Angeles International Airport; the program involves Mullen’s Class 1 EV cargo vans. The world’s largest aviation services company, Menzies operates in 250-plus airports in 58 countries, providing ground, air cargo and fuel services to commercial airports and airlines. Menzies is piloting Mullen Automotive electric vans and Loop Global charging infrastructure across its operations at LAX; the program is part of Menzies commitment to identify innovative solutions as it works to become carbon neutral by…

Continue Reading

ThursdayFeb 02, 2023 1:26 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Elevate Drug Delivery Across Blood-Brain Barrier by ~1,900%

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed its patented DehydraTECH(TM) technology, which is designed for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. “DehydraTECH increases effectiveness and improves how these ingredients enter the bloodstream. Benefits of DehydraTECH include: improved speed of onset, with effects felt in minutes; increased bioavailability, with more of the drug delivered into the bloodstream; increased brain absorption, with testing suggesting up to 10x improvement; and improved drug potency, with more of the ingested product made available in the bloodstream requiring lower dosages,” a recent article reads. “Animal studies…

Continue Reading

WednesdayFeb 01, 2023 11:14 am

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives Approval for First-in-Human Dosing of Proprietary DMT Molecule

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has received key approval to initiate human dosing of CYB004, its proprietary deuterated N,N-dimethyltryptamine (“DMT”) molecule, through a protocol amendment to its ongoing CYB004-E phase 1 trial. The approval came from an independent ethics committee in the Netherlands. The first-ever trial that evaluates deuterated DMT in humans, the study is being conducted at the Centre for Human Drug Research in the Netherlands; it is the largest-ever Phase 1 DMT trial conducted to date. Based on previous studies, CYB004 has shown potential to deliver an improved bioavailability…

Continue Reading

TuesdayJan 31, 2023 12:00 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT), Fr8App Partners with Leading Mexico-Based Trucking Company to Expand Services

Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning and offers a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region, is partnering with a leading transportation company in Mexico: Majoba Logistics. Fr8App is onboarding MAJOBA Logistics with an eye on expanding transportation capacity for its private fleet service. According to the announcement, Majoba Logistics’ fleet of vehicles will be added to the Fr8App platform in a move that provides a wider range of transportation options as well as more efficient and cost-effective services to customers.…

Continue Reading

Contact us: (512) 354-7000